Medical Condition News

RSS

Early autism diagnosis breakthrough: machine learning uses eye movements on real and artificial faces

An innovative autism spectrum disorder (ASD) detection technique for children by examining eye movement.

19 Sep 2023

New treatment approach effectively treats the most aggressive forms of prostate cancer

Researchers at the University of Chicago Medicine Comprehensive Cancer Center established "proof-of-concept" for a new treatment approach that was able to effectively treat the most aggressive forms of prostate cancer. The treatment showed complete tumor control and long-lasting survival without side effects in a mouse model of advanced prostate cancer.

19 Sep 2023

AR headset proven effective digital tool for improving posture in people with Parkinson’s disease

An augmented-reality headset is an effective digital tool for improving posture and gait in people with Parkinson's disease, according to a recent Cleveland Clinic trial. Findings were published in Neurorehabilitation and Neural Repair.

19 Sep 2023

Nanoparticle gene delivery system shows promise for treating ARDS

Discovery from the lab of Youyang Zhao, PhD, from Stanley Manne Children's Research Institute at Ann & Robert H. Lurie Children's Hospital of Chicago offers promising treatment approaches for acute respiratory distress syndrome (ARDS) in the elderly that can be caused by severe COVID-19, pneumonia, flu or sepsis. Currently there are no pharmacological or cell-based treatments for ARDS.

19 Sep 2023

New study debunks the myth that almonds are bad for weight loss

When it comes to weight loss, nuts can get a bad rap – while they're high in protein, they're also high in fats, and this often deters those looking to shed a few kilos. But new research from the University of South Australia shows that you can eat almonds and lose weight too.

19 Sep 2023

Ongoing gene therapy trials have driven increased use of ALS genetic testing, finds study

Researchers at The Ohio State University Wexner Medical Center and College of Medicine led the creation of evidence-based consensus guidelines for genetic testing and counseling for patients with amyotrophic lateral sclerosis (ALS), a neurodegenerative disease that affects the cells in the brain and spine.

19 Sep 2023

Researchers identify new blood marker for dopamine system damage

The marker in question is called DOPA decarboxylase (DCC). In the current study, DCC was found to be elevated in individuals with Parkinson's disease as well as in people with other diseases that result in dopamine deficiency in the brain. However, the marker was normal in other brain diseases such as Alzheimer's disease. The researchers even noticed that DCC was elevated in individuals with Parkinson's many years before they developed any symptoms.

19 Sep 2023

Telecare improves outcomes for patients with dementia and lightens the load for unpaid caregivers

A UCSF telecare program that improves outcomes for patients with dementia and lightens the load for unpaid caregivers also has the surprising bonus of cutting Medicare costs, according to UC San Francisco research.

19 Sep 2023

Adaptive platform trial shows promise for finding new glioblastoma therapies

An innovative phase 2 clinical trial led by Dana-Farber Cancer Institute in collaboration with 10 major brain tumor centers around the country and designed to find new potential treatments for glioblastoma has reported initial results in the Journal of Clinical Oncology. While none of the three therapeutics tested so far improved overall survival of patients, this adaptive platform trial, the first of its kind in neuro-oncology, has the potential to rapidly and efficiently identify therapies that benefit patients.

19 Sep 2023

Nano-based cancer therapies may be less effective in younger patients, finds study

Researchers at The University of Texas MD Anderson Cancer Center have discovered that certain nano-based cancer therapies may be less effective in younger patients, highlighting the need for further investigation into the impact of aging on the body's ability to respond to treatment.

19 Sep 2023

New study suggests higher buprenorphine doses could help save lives

Individuals with opioid use disorder who were prescribed a lower buprenorphine dose were 20% more likely to discontinue treatment than those on a higher dose, according to a study of patients prescribed buprenorphine in Rhode Island from 2016 to 2020, as fentanyl became widely available.

19 Sep 2023

New CAR T cell therapy approach minimizes severe side effects

In recent years, cancer researchers have hailed the arrival of chimeric antigen receptor T cell (CAR T) therapy, which has delivered promising results, transforming the fight against various forms of cancer. The process involves modifying patients' T-cells to target cancer cells, resulting in remarkable success rates for previously intractable forms of cancer.

19 Sep 2023

Analyzing development of improved child-resistant medication dispensing and tracking systems

Attention-deficit/hyperactivity disorder (ADHD) is among the most common pediatric neurodevelopmental disorders. In 2019, nearly 10% of United States (U.S.) children had a diagnosis of ADHD. Approximately 3.3 million children, or roughly 5 out of every 100 children in the U.S., are currently prescribed medication for ADHD.

19 Sep 2023

New tool may help identify inflammatory breast cancer quicker and at earlier stages

A new diagnostic scoring system, developed by renowned breast cancer experts, is now available as an easy-to-use online tool through Susan G. Komen®, the world's leading breast cancer organization.

19 Sep 2023

Gaining new insights into neurological diseases by studying circular RNAs in brain cells

Researchers are gaining new insights into neurological diseases by studying circular RNAs (circRNAs) in brain cells.

19 Sep 2023

New implantable device carries insulin-producing islet cells to control diabetes

One promising approach to treating Type 1 diabetes is implanting pancreatic islet cells that can produce insulin when needed, which can free patients from giving themselves frequent insulin injections.

19 Sep 2023

Uniink: A new 3D bioprinted cell therapy approach for Type 1 diabetes

Javier Ramón Azcón, an ICREA research professor and the leader of the Biosensors for Bioengineering group at the Institute for Bioengineering of Catalonia (IBEC), has been granted an "ERC Proof of Concept Grant."

18 Sep 2023

Unlocking the secret soldiers: How dendritic cells could revolutionize cancer immunotherapy

A recent review in the journal Immunity delves into the crucial role of dendritic cells (DCs) in shaping T-cell responses in cancer, highlighting their importance in both priming anti-tumor immunity and in ongoing immune interactions within tumors. The findings underscore the potential of DCs as key targets for next-generation cancer immunotherapies.

18 Sep 2023

Researchers identify key mechanisms to address future treatments for hereditary blindness

There are still many enigmas about the mechanism of action of the CERKL gene, which causes retinitis pigmentosa and other hereditary vision diseases.

18 Sep 2023

Study highlights a promising therapy to mitigate spaceflight-induced bone loss

A new study published in a Nature Partner Journal, npj Microgravity, finds an engineered compound given to mice aboard the International Space Station (ISS) largely prevented the bone loss associated with time spent in space.

18 Sep 2023

Medical Condition News

Early autism diagnosis breakthrough: machine learning uses eye movements on real and artificial faces

New treatment approach effectively treats the most aggressive forms of prostate cancer

AR headset proven effective digital tool for improving posture in people with Parkinson’s disease

Nanoparticle gene delivery system shows promise for treating ARDS

New study debunks the myth that almonds are bad for weight loss

Ongoing gene therapy trials have driven increased use of ALS genetic testing, finds study

Researchers identify new blood marker for dopamine system damage

Telecare improves outcomes for patients with dementia and lightens the load for unpaid caregivers

Adaptive platform trial shows promise for finding new glioblastoma therapies

Nano-based cancer therapies may be less effective in younger patients, finds study

New study suggests higher buprenorphine doses could help save lives

New CAR T cell therapy approach minimizes severe side effects

Analyzing development of improved child-resistant medication dispensing and tracking systems

New tool may help identify inflammatory breast cancer quicker and at earlier stages

Gaining new insights into neurological diseases by studying circular RNAs in brain cells

New implantable device carries insulin-producing islet cells to control diabetes

Uniink: A new 3D bioprinted cell therapy approach for Type 1 diabetes

Unlocking the secret soldiers: How dendritic cells could revolutionize cancer immunotherapy

Researchers identify key mechanisms to address future treatments for hereditary blindness

Study highlights a promising therapy to mitigate spaceflight-induced bone loss

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News